Exposure to 1-bromopropane induces microglial changes and oxidative stress in the rat cerebellum

Toxicology

Volumn 302, Issue 1, 2012, Pages 18-24

  Subramanian, Kaviarasan ^a   Mohideen, Sahabudeen Sheik ^a   Suzumura, Akio ^b   Asai, Naoya ^a   Murakumo, Yoshiki ^c   Takahashi, Masahide ^a   Jin, Shijie ^b   Zhang, Lingyi ^a   Huang, Zhenlie ^a   Ichihara, Sahoko ^d   Kitoh, Junzoh ^b   Ichihara, Gaku ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MIE UNIVERSITY   (Japan)

Author keywords

1 Bromopropane; Microglia; Neurotoxicity; Oxidative stress

Indexed keywords

1 BROMOPROPANE; CARBONYL DERIVATIVE; CD11B ANTIGEN; GLYCOPROTEIN P 15095; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SOLVENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SOLVENT EFFECT; WHITE MATTER;

ANIMALS; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCARBONS, BROMINATED; MALE; MICROGLIA; NITRIC OXIDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SOLVENTS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS;

EID: 84865990410     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.07.006     Document Type: Article

References (42)

1. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 2004, 3:205-214.
2. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2001, 2:325-334.
3. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992, 587:250-256.
4. Butterfield D.A., Stadman E.R. Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 1997, 2:161-191.
5. Calingasan N.Y., Park L.C., Calo L.L., Trifiletti R.R., Gandy S.E., Gibson G.E. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am. J. Pathol. 1998, 153:599-610.
6. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 1992, 149:2736-2741.
7. Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage the microglia. FEBS Lett. 1987, 223:284-288.
8. Colton C.A., Gilbert D.L. Microglia an in vivo source of reactive oxygen species in the brain. Adv. Neurol. 1993, 59:321-326.
9. Danielson S.R., Andersen J.K. Oxidative and nitrative protein modifications in Parkinson's disease. Free Radic. Biol. Med. 2008, 44:1787-1794.
10. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12:388-399.
11. Davis E.J., Foster T.D., Thomas W.E. Cellular forms and functions of brain microglia. Brain Res. Bull. 1994, 34:73-78.
12. Emerit J., Edeas M., Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 2004, 58:39-46.
13. Giulian D., Chen J., Ingeman J.E., George J.K., Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J. Neurosci. 1989, 9:4416-4429.
14. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 1999, 22:219-240.
15. Ichihara G. Neuro-reproductive toxicities of 1-bromopropane and 2-bromopropane. Int. Arch. Occup. Environ. Health 2005, 78:79-96.
16. Ichihara G., Kitoh J., Yu X., Asaeda N., Iwai H., Kumazawa T., Shibata E., Yamada T., Wang H., Xie Z., Takeuchi Y. 1-Bromopropane an alternative to ozone layer depleting solvents, is dose-dependently neurotoxic to rats in long-term inhalation exposure. Toxicol. Sci. 2000, 55:116-123.
17. Ichihara G., Li W., Shibata E., Ding X., Wang H., Liang Y., Peng S., Itohara S., Kamijima M., Fan Q., Zhang Y., Zhong E., Wu X., Valentine W.M., Takeuchi Y. Neurologic abnormalities in workers of a 1-bromopropane factory. Environ. Health Perspect. 2004, 112:1319-1325.
18. Ichihara G., Miller J., Ziolkowska A., Itohara S., Takeuchi Y. Neurological disorders in three workers exposed to 1-bromopropane. J. Occup. Health 2002, 44:1-7.
19. Li W., Shibata E., Zhou Z., Ichihara S., Wang H., Wang Q., Li J., Zhang L., Wakai K., Takeuchi Y., Ding X., Ichihara G. Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane. J. Occup. Environ. Med. 2010, 52:769-777.
20. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
21. Liu F., Ichihara S., Mohideen S.S., Sai U., Kitoh J., Ichihara G. Comparative toxicity on susceptibility to 1-bromopropane in three mice strains. Toxicol. Sci. 2009, 112:100-110.
22. Majersik J.J., Caravati E.M., Steffens J.D. Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin. Toxicol. (Phila.) 2007, 45:270-276.
23. Miwa T., Furukawa S., Nakajima K., Furukawa Y., Kohsaka S. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 1997, 50:1023-1029.
24. Mizuno T., Doi Y., Mizoguchi H., Jin S., Noda M., Sonobe Y., Takeuchi H., Suzumura A. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-beta neurotoxicity. Am. J. Pathol. 2011, 179:2016-2027.
25. Mohideen S.S., Ichihara G., Ichihara S., Nakamura S. Exposure to 1-bromopropane causes degeneration of noradrenergic axons in the rat brain. Toxicology 2011, 285:67-71.
26. Moore S., Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol. 1996, 48:441-460.
27. Morioka T., Kalehua A.N., Streit W.J. The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 1991, 11:966-973.
28. Muchowski P.J. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?. Neuron 2002, 35:9-12.
29. Nakajima K., Kohsaka S. Microglia: activation and their significance in the central nervous system. J. Biochem. 2001, 130:169-175.
30. National Toxicology Program, 2011. Studies of 1-bromopropane (CAS No. 106-94-5) in F344/N rats and B6C3F1 mice (Inhalation studies). In NTP technical report on the toxicology and carcinogenesis National Institutes of Health Public Health Service U.S. Department of Health and Human Services.
31. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
32. Ohnishi A., Ishidao T., Kasai T., Arashidani K., Hori H. Neurotoxicity of 1-bromopropane in rats. J. UOEH 1999, 21:23-28.
33. Parajuli B., Sonobe Y., Kawanokuchi J., Doi Y., Noda M., Takeuchi H., Mizuno T., Suzumura A. Immunoglobulin G(1) immune complex upregulates interferon-gamma-induced nitric oxide production via ERK1/2 activation in murine microglia. J. Neuroimmunol. 2012, 244:57-62.
34. Raymond L.W., Ford M.D. Severe illness in furniture makers using a new glue: 1-bromopropane toxicity confounded by arsenic. J. Occup. Environ. Med. 2007, 49:1009-1019.
35. Samukawa, M., Ichihara, G., Oka, N., Kusunoki, S., 2012. A case of severe neurotoxicity associated with exposure to 1-bromopropane, an alternative to ozone-depleting or global warming solvents. Arch Intern Med, in press.
36. Sclar G. Encephalomyeloradiculoneuropathy following exposure to an industrial solvent. Clin. Neurol. Neurosurg. 1999, 101:199-202.
37. Smith M.E., van der Maesen K., Somera F.P. Macrophage and microglial responses to cytokines in vitro: phagocytic activity proteolytic enzyme release, and free radical production. J. Neurosci. Res. 1998, 54:68-78.
38. Soltys Z., Ziaja M., Pawlinski R., Setkowicz Z., Janeczko K. Morphology of reactive microglia in the injured cerebral cortex Fractal analysis and complementary quantitative methods. J. Neurosci. Res. 2001, 63:90-97.
39. Takeuchi Y., Huang J., Shibata E., Hisanaga N., Ono Y. A trial to automatize an organic solvent exposure system for small animals. Jpn. J. Ind. Health 1989, 31:722.
40. Varnum M.M., Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60:251-266.
41. Watanabe Y., Nakagawa H., Sugimoto M., Sakai N. A case of cerebellar ataxia and peripheral neuropathy associated with exposure to 1-bromopropane. Sangyo Eiseigaku Zasshi 2006, 48:83-84.
42. Yu X., Ichihara G., Kitoh J., Xie Z., Shibata E., Kamijima M., Asaeda N., Takeuchi Y. Preliminary report on the neurotoxicity of 1-bromopropane an alternative solvent for chlorofluorocarbons. J. Occup. Health 1998, 40:234-235.